![Lone Veng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lone Veng
No más puestos en curso
Perfil
Lone Veng was the Chief Executive Officer at ResoTher Pharma AS.
Antiguos cargos conocidos de Lone Veng.
Empresas | Cargo | Fin |
---|---|---|
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Director Ejecutivo | 01/02/2023 |
Experiencias
Funciones ocupadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Health Technology |
- Bolsa de valores
- Insiders
- Lone Veng